Video Experimental Relacionado
Updated: Aug 19, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 2, 2013
Secuencias completas de nucleótidos del oncogén T24 del carcinoma de vejiga humana y su homólogo normal
Nature
|March 3, 1983
Resumen
Una única mutación puntual en el primer exón del gen c-Ha-ras-1 distingue el oncogén activado en las células de cáncer de vejiga T24 de su progenitor normal. Esta mutación altera tres aminoácidos en la proteína codificada.
Área de la Ciencia:
- Biología molecular La biología molecular.
- Oncología Oncología.
- Genética La genética.
Sus antecedentes:
- La línea T24 de carcinoma de vejiga humana contiene un oncogén activado.
- El gen progenitor celular normal se identifica como c-Ha-ras-1.
- Los oncogenes juegan un papel crítico en el desarrollo del cáncer.
Objetivo del estudio:
- Para analizar la secuencia de ADN del oncogén activado y su progenitor normal.
- Para identificar las diferencias genéticas entre las formas normales y activadas del gen c-Ha-ras-1.
- Comprender las bases moleculares de la activación de oncogenes en el cáncer de vejiga.
Principales métodos:
- Secuenciación del ADN del oncogén activado de la línea celular T24.
- Secuenciación del ADN de los alelos normales del gen c-Ha-ras-1.
- Análisis comparativo de secuencias para identificar mutaciones.
Principales resultados:
- El gen c-Ha-ras-1 tiene al menos cuatro exones.
- Una única mutación puntual dentro del primer exón diferencia el oncogén activado del gen normal.
- Los genes activados y normales codifican proteínas que difieren en tres residuos de aminoácidos.
- Un residuo de aminoácido alterado es un sitio de fosforilación importante conocido en la contraparte viral.
Conclusiones:
- Una mutación puntual específica en el primer exón del gen c-Ha-ras-1 es responsable de su activación como oncogén en el carcinoma de vejiga T24.
- Esta mutación conduce a alteraciones significativas en la proteína codificada, afectando potencialmente su función y regulación.
- La comprensión de estos cambios genéticos proporciona información sobre los mecanismos de activación de oncogenes en los cánceres humanos.
Videos de Conceptos Relacionados
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...